Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Merck leads $13M seed round for Christchurch biotech Precision Chroma, which develops 3D-printed chromatography for protein purification.
Amount Raised
$13 Million
Round Type
Seed
ChristchurchManufacturingBiotechnologyInvestors
Description
Precision Chroma, a Christchurch-based biotechnology startup, has closed a $13 million seed funding round led by Merck, with participation from M Ventures and support from the U.S. Biomedical Advanced Research and Development Authority (Barda). The capital will fund construction of a manufacturing plant in Christchurch and expand the team from six to 17-18 employees. Precision Chroma develops innovative 3D-printed agarose chromatography technology for direct affinity capture of therapeutic proteins, potentially streamlining biopharmaceutical manufacturing
Fundz sees it the moment Precision Chroma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Precision Chroma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.